<p>The present disclosure relates to compounds of formula I, compositions and methods for the treatment of hepatitis C virus (HCV) infection. Also disclosed are pharmaceutical compositions containing such compounds and methods for using these compounds in the treatment of HCV infection.</p>
申请公布号
TN2013000335(A1)
申请公布日期
2015.01.20
申请号
TN20130000335
申请日期
2013.08.02
申请人
BRISTOL-MYERS SQUIBB COMPANY
发明人
BENDER, JOHN, A.;LOPEZ, OMAR, D.;WANG, GAN;BELEMA, MAKONEN;KADOW, JOHN, F.
